PSMA radioligand uptake as a biomarker of neoangiogenesis in solid tumours: diagnostic or theragnostic factor?

A Rizzo, S Dall'Armellina, DA Pizzuto, G Perotti… - Cancers, 2022 - mdpi.com
Simple Summary Positron emission tomography/computed tomography (PET/CT) has an
increasingly relevant role in the management of oncological patients. It consists of the …

The emerging role of PET/CT with PSMA-targeting radiopharmaceuticals in clear cell renal cancer: an updated systematic review

A Rizzo, M Racca, S Dall'Armellina, P Rescigno… - Cancers, 2023 - mdpi.com
Simple Summary Positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals is a relatively …

[HTML][HTML] Impact of prostate-specific membrane antigen positron emission tomography/computed tomography in the management of oligometastatic renal cell …

C Udovicich, J Callahan, M Bressel, WL Ong… - European Urology Open …, 2022 - Elsevier
Background Prostate-specific membrane antigen (PSMA) is overexpressed in the
neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence …

PSMA PET/CT in renal cell carcinoma: an overview of current literature

S Muselaers, S Erdem, R Bertolo, A Ingels… - Journal of Clinical …, 2022 - mdpi.com
Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission
tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly …

Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study

G Wang, L Li, J Wang, J Zang, J Chen, Y Xiao… - European Journal of …, 2023 - Springer
Purpose This pilot study was prospectively designed to evaluate and compare the
diagnostic value of PET/CT using a PSMA-specific tracer [68Ga] Ga-P16-093 and a glucose …

Prostate-Specific Membrane Antigen Positron Emission Tomography Oncological Applications beyond Prostate Cancer in Comparison to Other Radiopharmaceuticals

A Miceli, V Liberini, G Pepe, F Dondi, A Vento… - Diagnostics, 2024 - mdpi.com
Background: Prostate-specific membrane antigen (PSMA) is a type II transmembrane
glycoprotein overexpressed on the surface of tumor cells in most of the patients affected by …

[HTML][HTML] The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Primary Staging of Selected Renal Tumours …

A Tariq, A Pearce, H Rhee, S Kyle… - European Urology …, 2024 - Elsevier
Background Accurate primary staging of renal cancer with conventional imaging is
challenging. Prostate-specific membrane antigen (PSMA) positron emission …

High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry

D Gasparro, M Scarlattei, EM Silini, S Migliari… - Diagnostics, 2023 - mdpi.com
In oligo-metastatic renal cell carcinoma (RCC), neither computed tomography (CT) nor bone
scan is sensitive enough to detect small tumor deposits hampering early treatment and …

[HTML][HTML] SABR for oligometastatic renal cell carcinoma

C David, A Muhammad, U Cristian, T Ben… - Clinical and …, 2024 - Elsevier
Stereotactic ablative body radiotherapy (SABR) aims to accurately deliver a higher than
conventional dose of radiotherapy to a well-defined target tumour incorporating advanced …

Potential role of 68Ga-PSMA PET/CT in metastatic renal cell cancer: A prospective study

P Aggarwal, H Singh, CK Das, RS Mavuduru… - European Journal of …, 2024 - Elsevier
Purpose Prostate-specific membrane antigen (PSMA), in addition to its utility in prostate
cancer, is also an angiogenic imaging marker for hypervascular tumors like renal cell …